购物车
全部删除
您的购物车当前为空
LY2090314 是GSK-3抑制剂,抑制 GSK-3α (IC50:1.5 nM) 和 GSK-3β (IC50:0.9 nM)。


为众多的药物研发团队赋能,
让新药发现更简单!
LY2090314 是GSK-3抑制剂,抑制 GSK-3α (IC50:1.5 nM) 和 GSK-3β (IC50:0.9 nM)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 389 | 现货 | |
| 2 mg | ¥ 562 | 现货 | |
| 5 mg | ¥ 889 | 现货 | |
| 10 mg | ¥ 1,420 | 现货 | |
| 25 mg | ¥ 2,560 | 现货 | |
| 50 mg | ¥ 3,890 | 现货 | |
| 100 mg | ¥ 5,560 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 987 | 现货 |
LY2090314 相关产品
| 产品描述 | LY2090314, an effective GSK-3α/β inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. |
| 靶点活性 | GSK-3α:1.5 nM, GSK-3β:0.9 nM |
| 体内活性 | LY2090314在实体瘤癌异种移植模型中提高了顺铂和卡铂的疗效。[1] |
| 分子量 | 512.53 |
| 分子式 | C28H25FN6O3 |
| CAS No. | 603288-22-8 |
| Smiles | Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1 |
| 密度 | 1.55 g/cm3 (Predicted) |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 35.36 mg/mL (68.99 mM), Sonication is recommended. Ethanol: 2 mg/mL (3.9 mM), Heating is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.9 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容